Australia's Microba Life Sciences gains most in two weeks on Q3 results

Microba Life Sciences

23/04/2024 03:35

** Shares of Australia's Microba Life Sciences  MAP.AX  rise
as much as 8.8% to A$0.185, marking its biggest intraday pct
gain since April 9
    ** Stock trims some gains to last trade at 7.4%
    ** Precision microbiome co posts Q3 unaudited revenue of A$4
mln ($2.58 mln), up 82% Q/Q 
    ** Stock down 5.6% YTD, as of last close 


($1 = 1.5485 Australian dollars)

 (Reporting by Roshan Thomas in Bengaluru)
 ((Roshan.Thomas@thomsonreuters.com))